Baek JH - Search Results

1

Bevacizumab as a second- or later-line of treatment for metastatic colorectal cancer.

Park LC, Lee HS, Shin SH, Park SJ, Park MI, Oh SY, Kwon HC, Baek JH, Choi YJ, Kang MJ, Kim YS. Park LC, et al. Among authors: baek jh. World J Gastroenterol. 2012 Mar 14;18(10):1104-9. doi: 10.3748/wjg.v18.i10.1104. World J Gastroenterol. 2012. PMID: 22416186 Free PMC article.

2

Outpatient-basis chemotherapy of oxaliplatin, 5-fluorouracil, and leucovorin as first-line treatment for patients with metastatic or recurrent colorectal cancer.

Moon JH, Kim JG, Sohn SK, Baek JH, Cho YY, Chae YS, Ahn BM, Kim SN, Lee SJ, Lee IT, Choi GS, Jun SH. Moon JH, et al. Among authors: baek jh. J Korean Med Sci. 2007 Jun;22(3):400-4. doi: 10.3346/jkms.2007.22.3.400. J Korean Med Sci. 2007. PMID: 17596644 Free PMC article.

3

A multi-center phase II study of docetaxel plus cisplatin as first-line therapy in patients with metastatic squamous cell esophageal cancer.

Kim JY, Do YR, Park KU, Kim MK, Lee KH, Bae SH, Ryoo HM, Baek JH, Song HS. Kim JY, et al. Among authors: baek jh. Cancer Chemother Pharmacol. 2010 May;66(1):31-6. doi: 10.1007/s00280-009-1130-6. Epub 2009 Sep 18. Cancer Chemother Pharmacol. 2010. PMID: 19763571 Clinical Trial.

4

Prospective phase II trial of a combination of gemcitabine and UFT as first-line treatment in elderly patients with advanced non-small cell lung cancer.

Baek JH, Kim H, Ahn JJ, Jegal Y, Seo KW, Ra SW, Park CR, Jung JP, Kim JW, Lee YJ, Cha HJ, Kwon WJ, Noh YJ, Oh S, Park JH, Min YJ. Baek JH, et al. Lung Cancer. 2012 Jun;76(3):368-72. doi: 10.1016/j.lungcan.2011.11.021. Epub 2011 Dec 20. Lung Cancer. 2012. PMID: 22192919 Clinical Trial.

5

A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02.

Choi YH, Oh SC, Kim JS, Nam SH, Kim BS, Cho SH, Chung IJ, Song EK, Yim CY, Baek JH, Jeung HC, Hong YS, Yang SH, Kang HJ. Choi YH, et al. Among authors: baek jh. Cancer Chemother Pharmacol. 2012 Nov;70(5):665-72. doi: 10.1007/s00280-012-1956-1. Epub 2012 Aug 25. Cancer Chemother Pharmacol. 2012. PMID: 22926638 Clinical Trial.

6

Noninterventional observational study using high-dose controlled-release oxycodone (CR oxycodone) for cancer pain management in outpatient clinics.

Baek SK, Shin HW, Choi YJ, Zang DY, Cho DY, Ryoo HM, Baek JH, Kim SY, Song HS. Baek SK, et al. Among authors: baek jh. Pain Med. 2013 Dec;14(12):1866-72. doi: 10.1111/pme.12228. Epub 2013 Sep 6. Pain Med. 2013. PMID: 24010556

7

Clinical Usefulness of Hydromorphone-OROS in Improving Sleep Disturbances in Korean Cancer Patients: A Multicenter, Prospective, Open-Label Study.

Shin SH, Lee HS, Kim YS, Choi YJ, Kim SH, Kwon HC, Oh SY, Kang JH, Sohn CH, Lee SM, Baek JH, Min YJ, Kim C, Chung JS. Shin SH, et al. Among authors: baek jh. Cancer Res Treat. 2014 Oct;46(4):331-8. doi: 10.4143/crt.2013.130. Epub 2014 Jul 21. Cancer Res Treat. 2014. PMID: 25043822 Free PMC article.

8

Multi-center Randomized Phase II Study of Weekly Docetaxel Versus Weekly Docetaxel-plus-Oxaliplatin as a Second-line Chemotherapy for Patients with Advanced Gastric Cancer.

Kim JY, Ryoo HM, Bae SH, Kang BW, Chae YS, Yoon S, Baek JH, Kim MK, Lee KH, Lee SA, Song HS, Kim JG. Kim JY, et al. Among authors: baek jh. Anticancer Res. 2015 Jun;35(6):3531-6. Anticancer Res. 2015. PMID: 26026121 Clinical Trial.

9

Transdermal granisetron versus palonosetron for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: a multicenter, randomized, open-label, cross-over, active-controlled, and phase IV study.

Seol YM, Kim HJ, Choi YJ, Lee EM, Kim YS, Oh SY, Koh SJ, Baek JH, Lee WS, Joo YD, Lee HG, Yun EY, Chung JS. Seol YM, et al. Among authors: baek jh. Support Care Cancer. 2016 Feb;24(2):945-952. doi: 10.1007/s00520-015-2865-8. Epub 2015 Aug 12. Support Care Cancer. 2016. PMID: 26265119 Clinical Trial.

10

Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG).

Jung M, Ryu MH, Oh DY, Kang M, Zang DY, Hwang IG, Lee KW, Kim KH, Shim BY, Song EK, Sym SJ, Han HS, Park YL, Kim JS, Lee HW, Lee MH, Koo DH, Song HS, Lee N, Yang SH, Choi DR, Hong YS, Lee KE, Maeng CH, Baek JH, Kim S, Kim YH, Rha SY, Cho JY, Kang YK. Jung M, et al. Among authors: baek jh. Gastric Cancer. 2018 Sep;21(5):819-830. doi: 10.1007/s10120-018-0806-1. Epub 2018 Feb 9. Gastric Cancer. 2018. PMID: 29427038 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,531 results

Search Page

Filters